Status:
COMPLETED
The Evaluation and Standardization of Ginseng and Its Components for Blood Pressure Regulation
Lead Sponsor:
Unity Health Toronto
Collaborating Sponsors:
Heart and Stroke Foundation of Ontario
Conditions:
Hypertension
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
While the use of herbals is increasing considerably, their efficacy and safety in the humans remains largely unknown. This surge in demand prompts a call for its evaluation. Preliminary data demonstra...
Detailed Description
Individuals will arrive at the Risk Factor Modification Centre, St. Michael's Hospital between the hours of 8:00 and 10:00am after a 10 to 12-hour fast on seven separate mornings. They will not have c...
Eligibility Criteria
Inclusion
- Essential Hypertension
Exclusion
- Secondary Hypertension
- Diabetes
- Chronic Kidney Disease
- Liver Disease
- Unstable Angina
- Coronary / Cerebrovascular event in the previous 6 months
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00730951
Start Date
June 1 2007
End Date
March 1 2008
Last Update
July 31 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Nutrition and Risk Factor Modification Centre
Toronto, Ontario, Canada